A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide.

Autor: Chatzikyriakou P; Department of Medical and Molecular Genetics, King's College London, London, SE1 9RT, UK.; Comprehensive Cancer Centre, King's College London, London, SE5 8AF, UK., Brempou D; Department of Medical and Molecular Genetics, King's College London, London, SE1 9RT, UK., Quinn M; Department of Medical and Molecular Genetics, King's College London, London, SE1 9RT, UK., Fishbein L; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, Philadelphia, PA, USA.; Division of Endocrinology, Diabetes and Metabolism in the Department of Medicine Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA., Noberini R; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy., Anastopoulos IN; Department of Biomolecular Engineering, UC Santa Cruz Genomics Institute, University of California, Santa Cruz, Santa Cruz, CA, 95064, USA., Tufton N; Department of Endocrinology, St. Bartholomew's Hospital, Barts Health NHS Trust, and William Harvey Research Institute, Queen Mary University of London, London, UK., Lim ES; Department of Endocrinology, St. Bartholomew's Hospital, Barts Health NHS Trust, and William Harvey Research Institute, Queen Mary University of London, London, UK., Obholzer R; Department of ENT and Skull Base Surgery, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, UK., Hubbard JG; Department of Endocrine Surgery, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, UK., Moonim M; Department of Cellular Pathology, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, UK.; Imperial College Healthcare NHS Trust, London, UK., Bonaldi T; Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Via Adamello 16, 20139, Milan, Italy.; Department of Oncology and Hematology-Oncology, University of Milano, Via Festa del Perdono 7, 20122, Milan, Italy., Nathanson KL; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, Philadelphia, PA, USA., Izatt L; Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, UK., Oakey RJ; Department of Medical and Molecular Genetics, King's College London, London, SE1 9RT, UK. rebecca.oakey@kcl.ac.uk.

Publikováno v: Clinical epigenetics [Clin Epigenetics] 2023 Dec 20; Vol. 15 (1), pp. 196. Date of Electronic Publication: 2023 Dec 20.

Treatment outcome with a selective RET tyrosine kinase inhibitor selpercatinib in children with multiple endocrine neoplasia type 2 and advanced medullary thyroid carcinoma.

Autor: Shankar A; Children and Young People's Cancer Services, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: ananth.shankar@nhs.net., Kurzawinski T; Department of Endocrine Surgery, University College London Hospitals NHS Foundation Trust, London, UK., Ross E; Department of Paediatric Oncology, University Hospitals of Leicester NHS Trust, Leicester, UK., Stoneham S; Children and Young People's Cancer Services, University College London Hospitals NHS Foundation Trust, London, UK., Beale T; Department of Head and Neck Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Proctor I; Department of Cellular Pathology, University College London Hospitals NHS Foundation Trust, London, UK., Hulse T; Department of Paediatric Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Simpson K; Department of Pharmacy, University College London Hospitals NHS Foundation Trust, London, UK., Gaze MN; Department of Oncology, University College London Hospitals NHS Foundation Trust, National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK., Cattaneo E; Children's and Adolescent Services, East Suffolk and North Essex NHS Foundation Trust, Colchester, UK., Gevers E; Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London and Department of Paediatric Endocrinology, Barts Health NHS Trust, London, UK., Marshall L; Department of Paediatric and Adolescent Oncology, The Royal Marsden NHS Foundation Trust, Sutton and The Institute of Cancer Research, London, UK., Hubbard JG; Department of Surgery, Guys & St Thomas' NHS Foundation Trust, London, UK., Brain C; Department of Paediatric Endocrinology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Oct 11; Vol. 158, pp. 38-46. Date of Electronic Publication: 2021 Oct 11.

Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: a single centre report from South Africa.

Autor: Govind, Kamal¹ kamal.govind04@gmail.com, Paruk, Imran M.¹, Motala, Ayesha A.¹

Publikováno v: BMC Endocrine Disorders. 4/25/2024, Vol. 24 Issue 1, p1-9. 9p.

The Parathyroid Gland: An Overall Review of the Hidden Organ for Radiologists.

Autor: Suho Kim¹, Jung Hee Shin¹ helena35@hanmail.net, Soo Yeon Hahn¹, Haejung Kim¹, Myoung Kyoung Kim¹

Publikováno v: Journal of the Korean Society of Radiology (2951-0805). Mar2024, Vol. 85 Issue 2, p327-344. 18p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.